Evidence map›Paper›PMID 29474096›Full record

ReviewThe British journal of radiology2018

Theranostic radiopharmaceuticals: established agents in current use.

James R Ballinger

Open access · greenAbstract readReview
In one paragraph

Review in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 108 citations in OpenAlex.

  1. [EJNMMI research · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Hydroxyquinoline-functionalised aza-crown macrocycles for lanthanide coordination.Dalton transactions (Cambridge, England : 2003) · 2026
    Article
  6. Review
  7. Production ofFrontiers in nuclear medicine · 2025
    Article
  8. Review
  9. Article
  10. p53 stabilisation potentiates [European journal of nuclear medicine and molecular imaging · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

James R Ballinger1 Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London , London , UK.
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although use of the term "theranostic" is relatively recent, the concept goes back to the earliest days of nuclear medicine, with the use of radioiodine for diagnosis and therapy of benign and malignant thyroid disease being arguably the most successful molecular radiotherapy in history. A diagnostic scan with

Indexed as

Radiopharmaceuticals3-IodobenzylguanidineAntigens, CD20Bone NeoplasmsDipeptidesDiphosphonatesDrug ApprovalForecastingHeterocyclic Compounds, 1-RingHodgkin DiseaseHumansIodine RadioisotopesLutetiumOctreotideOrganometallic CompoundsProstate-Specific Antigen3-IodobenzylguanidineAntigens, CD20DipeptidesDiphosphonatesgallium Ga 68 dotatateHeterocyclic Compounds, 1-RingIodine RadioisotopesLutetiumlutetium Lu 177 dotatateOctreotideOrganometallic CompoundsPluvictoProstate-Specific AntigenRadiopharmaceuticalsSomatostatin

Identifiers

PMID29474096
PMCPMC6475961
OpenAlexW2788279058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.